- Home
- TLF vs FBIOP Comparison
TLF vs FBIOP Comparison
Compare TLF & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLF
- FBIOP
- Stock Information
- Founded
- TLF 1980
- FBIOP N/A
- Country
- TLF United States
- FBIOP United States
- Employees
- TLF N/A
- FBIOP 101
- Industry
- TLF Apparel
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- TLF Consumer Discretionary
- FBIOP Health Care
- Exchange
- TLF Nasdaq
- FBIOP Nasdaq
- Market Cap
- TLF N/A
- FBIOP N/A
- IPO Year
- TLF N/A
- FBIOP N/A
- Fundamental
- Price
- TLF $3.04
- FBIOP $8.47
- Analyst Decision
- TLF
- FBIOP
- Analyst Count
- TLF 0
- FBIOP 0
- Target Price
- TLF N/A
- FBIOP N/A
- AVG Volume (30 Days)
- TLF 17.3K
- FBIOP N/A
- Earning Date
- TLF 11-11-2025
- FBIOP N/A
- Dividend Yield
- TLF 49.51%
- FBIOP N/A
- EPS Growth
- TLF N/A
- FBIOP N/A
- EPS
- TLF 0.08
- FBIOP N/A
- Revenue
- TLF $74,639,000.00
- FBIOP N/A
- Revenue This Year
- TLF N/A
- FBIOP N/A
- Revenue Next Year
- TLF N/A
- FBIOP N/A
- P/E Ratio
- TLF $38.30
- FBIOP N/A
- Revenue Growth
- TLF N/A
- FBIOP N/A
- 52 Week Low
- TLF $2.69
- FBIOP N/A
- 52 Week High
- TLF $5.48
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- TLF 50.75
- FBIOP 51.78
- Support Level
- TLF N/A
- FBIOP $8.65
- Resistance Level
- TLF $3.11
- FBIOP $9.46
- Average True Range (ATR)
- TLF 0.07
- FBIOP 0.64
- MACD
- TLF -0.11
- FBIOP -0.02
- Stochastic Oscillator
- TLF 93.38
- FBIOP 35.90
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.